News and blogs
162 results found.
How dangerous is Covid-19 for people with blood cancer?
Read Blood Cancer UK's article looking at study's on how dangerous Covid-19 is for people with different types of blood cancer.
How was the coronavirus vaccine created?
Learn how the coronavirus vaccines were made, including information on clinical trials, vaccine approvals and long-term side effects.
The coronavirus vaccine: what you need to know
We outline what we know about the potential coronavirus vaccines, and explore what they could mean for people with blood cancer.
How does the coronavirus affect people with blood cancer?
Blood Cancer UK are funding vital research that will explore how different types of blood cancer might affect someone’s individual level of risk from coronavirus.
Our aim to beat blood cancer in a generation
Learn how Blood Cancer UK aim to beat blood cancer in a generation.
Does having blood cancer put you at greater risk from the coronavirus?
Find out if people with blood cancers are more likely to suffer severe and life-threatening COVID-19 than healthy individuals.
How could a coronavirus vaccine help people with blood cancer?
Find out how coronavirus vaccines work and their potential to protect people with blood cancer.
EHA annual conference 2020: the promising future of blood cancer research
Blood Cancer UK rounds up the exciting breakthroughs in blood cancer research discussed at this year’s European Haematology Association conference.
What effect is COVID-19 having on blood cancer research?
Find out how blood cancer research is being effected by the COVID-19 pandemic.
New research hope for those with a rare type of leukaemia
Blood Cancer UK research fellow, Dr Marc Mansour and his team, have come to understand more about why some types of T-cell acute lymphoblastic leukaemia (T-ALL) stop responding to chemotherapy, and how we might overcome it in the future.
Why are people with blood cancer being told to shield for 12 weeks?
Here's the information we have on why people with blood cancer are being asked to shield.
Could a blood cancer drug be used to help people with COVID-19?
Calquence is being trialled in patients with COVID-19 who are critically ill, in the hope that it may reduce damage to their lungs.
Could a blood cancer drug be used to help people with COVID-19?
Calquence is being trialled in patients with COVID-19 who are critically ill, in the hope that it may reduce damage to their lungs.
Leukaemia protective role of Y chromosome gene discovered
Scientists funded by Blood Cancer UK have discovered the first leukaemia protective gene that is specific to the male-only Y chromosome.
Leukaemia - how we can use information to treat it
Why finding about how we get leukaemia in the first place is so important for developing new treatments.
How does the immune system destroy Hodgkin lymphoma?
In Hodgkin lymphoma, the cells which are the root cause of the cancer are hidden within a much larger number of white blood cells.
Researchers say blood cancer beaten in a few decades
Blood cancer researchers are excited about the future and say the scientific progress made mean blood cancer can be beaten in the next few decades.
Blood cancer treatment - weapon of war
As we pay tribute to the soldiers of World War I, we look at the surprising link between the battlefields of France and blood cancer research.
Lymphoma: new tool fights most dangerous
UK scientists funded by Bloodwise have found a new way to identify people with lymphoma who are less likely to respond to standard drugs.
The American Society of Haematology (ASH) Annual Meeting saw 30,000 experts to discuss new research examining blood cancers and other blood disorders.
The American Society of Haematology (ASH) Annual Meeting saw 30,000 experts to discuss new research examining blood cancers and other blood disorders.